...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: IR response
8
May 04, 2022 03:37PM
6
May 06, 2022 12:22AM
3
May 06, 2022 10:15AM

The problem I see with Open-Label Study, ...why would patients admitted to the hospital with COVID partake in the study if they are not given apabetalone? What benefit do they get out of the study except being a good samaritan??? Thoughts?

 

Koo

 

3
May 06, 2022 09:14PM
1
May 06, 2022 10:31PM
2
May 07, 2022 01:38AM
3
May 07, 2022 07:51PM
Share
New Message
Please login to post a reply